
Michael Lee
Examiner (ID: 12147, Phone: (571)272-7349 , Office: P/2422 )
| Most Active Art Unit | 2422 |
| Art Unit(s) | 2622, 2422, 2714, 2614, 2711, 1661, 2602 |
| Total Applications | 3017 |
| Issued Applications | 2434 |
| Pending Applications | 176 |
| Abandoned Applications | 432 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10654630
[patent_doc_number] => 20160000775
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-07
[patent_title] => 'USE OF HIGH DOSE LAQUINIMOD FOR TREATING MULTIPLE SCLEROSIS'
[patent_app_type] => utility
[patent_app_number] => 14/854849
[patent_app_country] => US
[patent_app_date] => 2015-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14301
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 25
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14854849
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/854849 | USE OF HIGH DOSE LAQUINIMOD FOR TREATING MULTIPLE SCLEROSIS | Sep 14, 2015 | Abandoned |
Array
(
[id] => 11850216
[patent_doc_number] => 20170224709
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-10
[patent_title] => 'METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE USING PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/502009
[patent_app_country] => US
[patent_app_date] => 2015-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 16606
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15502009
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/502009 | Methods for treating inflammatory bowel disease using prostate specific membrane antigen (PSMA) inhibitors | Aug 5, 2015 | Issued |
Array
(
[id] => 10987428
[patent_doc_number] => 20160184374
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-30
[patent_title] => 'SANDALWOOD OIL AND ITS USES'
[patent_app_type] => utility
[patent_app_number] => 14/812919
[patent_app_country] => US
[patent_app_date] => 2015-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 7297
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14812919
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/812919 | SANDALWOOD OIL AND ITS USES | Jul 28, 2015 | Abandoned |
Array
(
[id] => 11749226
[patent_doc_number] => 09707225
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-07-18
[patent_title] => 'Combinations of opioid/TLR4 antagonist and acetyl-para-aminophenol (APAP) for use in the treatment of pain'
[patent_app_type] => utility
[patent_app_number] => 14/812698
[patent_app_country] => US
[patent_app_date] => 2015-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4067
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14812698
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/812698 | Combinations of opioid/TLR4 antagonist and acetyl-para-aminophenol (APAP) for use in the treatment of pain | Jul 28, 2015 | Issued |
Array
(
[id] => 10684273
[patent_doc_number] => 20160030418
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-04
[patent_title] => 'METHOD FOR DECREASING LOW DENSITY LIPID PROTEIN'
[patent_app_type] => utility
[patent_app_number] => 14/807927
[patent_app_country] => US
[patent_app_date] => 2015-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4055
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14807927
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/807927 | METHOD FOR DECREASING LOW DENSITY LIPID PROTEIN | Jul 23, 2015 | Abandoned |
Array
(
[id] => 11901088
[patent_doc_number] => 09770509
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-26
[patent_title] => 'Self micro-emulsifying drug delivery system with increased bioavailability'
[patent_app_type] => utility
[patent_app_number] => 14/802837
[patent_app_country] => US
[patent_app_date] => 2015-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9445
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14802837
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/802837 | Self micro-emulsifying drug delivery system with increased bioavailability | Jul 16, 2015 | Issued |
Array
(
[id] => 10467090
[patent_doc_number] => 20150352105
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-10
[patent_title] => 'METHODS AND COMPOSITIONS FOR PREVENTION AND TREATMENT OF CARDIAC HYPERTROPHY'
[patent_app_type] => utility
[patent_app_number] => 14/745060
[patent_app_country] => US
[patent_app_date] => 2015-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 8819
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14745060
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/745060 | METHODS AND COMPOSITIONS FOR PREVENTION AND TREATMENT OF CARDIAC HYPERTROPHY | Jun 18, 2015 | Abandoned |
Array
(
[id] => 11655504
[patent_doc_number] => 09668478
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-06-06
[patent_title] => 'Pest controlling composition and method for controlling pest'
[patent_app_type] => utility
[patent_app_number] => 14/734910
[patent_app_country] => US
[patent_app_date] => 2015-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7594
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14734910
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/734910 | Pest controlling composition and method for controlling pest | Jun 8, 2015 | Issued |
Array
(
[id] => 10767778
[patent_doc_number] => 20160113934
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-28
[patent_title] => 'PRESERVATIVE FREE BIMATOPROST AND TIMOLOL SOLUTIONS'
[patent_app_type] => utility
[patent_app_number] => 14/733118
[patent_app_country] => US
[patent_app_date] => 2015-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1158
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14733118
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/733118 | PRESERVATIVE FREE BIMATOPROST AND TIMOLOL SOLUTIONS | Jun 7, 2015 | Abandoned |
Array
(
[id] => 10380585
[patent_doc_number] => 20150265592
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-24
[patent_title] => 'USE OF HIGH DOSE LAQUINIMOD FOR TREATING MULTIPLE SCLEROSIS'
[patent_app_type] => utility
[patent_app_number] => 14/731971
[patent_app_country] => US
[patent_app_date] => 2015-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14322
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 25
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14731971
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/731971 | USE OF HIGH DOSE LAQUINIMOD FOR TREATING MULTIPLE SCLEROSIS | Jun 4, 2015 | Abandoned |
Array
(
[id] => 10380705
[patent_doc_number] => 20150265713
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-24
[patent_title] => 'Phenylephrine Formulations With Improved Stability'
[patent_app_type] => utility
[patent_app_number] => 14/729371
[patent_app_country] => US
[patent_app_date] => 2015-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1370
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14729371
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/729371 | Phenylephrine formulations with improved stability | Jun 2, 2015 | Issued |
Array
(
[id] => 10669670
[patent_doc_number] => 20160015815
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-21
[patent_title] => 'PHENYLEPHRINE FORMULATIONS WITH IMPROVED STABILITY'
[patent_app_type] => utility
[patent_app_number] => 14/725098
[patent_app_country] => US
[patent_app_date] => 2015-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1339
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14725098
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/725098 | PHENYLEPHRINE FORMULATIONS WITH IMPROVED STABILITY | May 28, 2015 | Abandoned |
Array
(
[id] => 10373071
[patent_doc_number] => 20150258077
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-17
[patent_title] => 'SUBSTITUTED BENZTROPINE ANALOGS FOR TREATMENT OF DEMENTIA'
[patent_app_type] => utility
[patent_app_number] => 14/724253
[patent_app_country] => US
[patent_app_date] => 2015-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4287
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14724253
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/724253 | SUBSTITUTED BENZTROPINE ANALOGS FOR TREATMENT OF DEMENTIA | May 27, 2015 | Abandoned |
Array
(
[id] => 10450657
[patent_doc_number] => 20150335672
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-26
[patent_title] => 'Treatment of Diseases Using Combination of Ultraviolet Blood Irradiation and Antibiotics'
[patent_app_type] => utility
[patent_app_number] => 14/720354
[patent_app_country] => US
[patent_app_date] => 2015-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7205
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14720354
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/720354 | Treatment of Diseases Using Combination of Ultraviolet Blood Irradiation and Antibiotics | May 21, 2015 | Abandoned |
Array
(
[id] => 10365761
[patent_doc_number] => 20150250766
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-10
[patent_title] => 'FORMULATIONS OF BENDAMUSTINE'
[patent_app_type] => utility
[patent_app_number] => 14/714578
[patent_app_country] => US
[patent_app_date] => 2015-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8739
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14714578
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/714578 | Formulations of bendamustine | May 17, 2015 | Issued |
Array
(
[id] => 10405150
[patent_doc_number] => 20150290159
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-15
[patent_title] => 'PROPHYLACTIC/AMELIORATING AGENT FOR ADULT DISEASES COMPRISING 5-AMINOLEVULINIC ACID, DERIVATIVE OF 5-AMINOLEVULINIC ACID, OR SALT OF 5-AMINOLEVULINIC ACID OR THE DERIVATIVE OF 5-AMINOLEVULINIC ACID AS ACTIVE INGREDIENT'
[patent_app_type] => utility
[patent_app_number] => 14/707260
[patent_app_country] => US
[patent_app_date] => 2015-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8196
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14707260
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/707260 | Prophylactic/ameliorating agent for adult diseases comprising 5-aminolevulinic acid, derivative of 5-aminolevulinic acid, or salt of 5-aminolevulinic acid or the derivative of 5-aminolevulinic acid as active ingredient | May 7, 2015 | Issued |
Array
(
[id] => 10339091
[patent_doc_number] => 20150224096
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-13
[patent_title] => 'USE AND COMPOSITION FOR TREATING DEMENTIA'
[patent_app_type] => utility
[patent_app_number] => 14/696861
[patent_app_country] => US
[patent_app_date] => 2015-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11898
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14696861
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/696861 | USE AND COMPOSITION FOR TREATING DEMENTIA | Apr 26, 2015 | Abandoned |
Array
(
[id] => 10339070
[patent_doc_number] => 20150224075
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-13
[patent_title] => 'OMEGA 3 FORMULATIONS FOR TREATMENT OF RISK FACTORS FOR CARDIOVASCULAR DISEASE AND PROTECTION AGAINST SUDDEN DEATH'
[patent_app_type] => utility
[patent_app_number] => 14/692503
[patent_app_country] => US
[patent_app_date] => 2015-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 12515
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14692503
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/692503 | OMEGA 3 FORMULATIONS FOR TREATMENT OF RISK FACTORS FOR CARDIOVASCULAR DISEASE AND PROTECTION AGAINST SUDDEN DEATH | Apr 20, 2015 | Abandoned |
Array
(
[id] => 10339109
[patent_doc_number] => 20150224115
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-13
[patent_title] => 'PRESERVATIVE FREE BIMATOPROST AND TIMOLOL SOLUTIONS'
[patent_app_type] => utility
[patent_app_number] => 14/691919
[patent_app_country] => US
[patent_app_date] => 2015-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3039
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14691919
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/691919 | Preservative free bimatoprost and timolol solutions | Apr 20, 2015 | Issued |
Array
(
[id] => 10743191
[patent_doc_number] => 20160089342
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-31
[patent_title] => 'METHOD OF INHIBITING XANTHINE OXIDASE ACTIVITY IN A CELL'
[patent_app_type] => utility
[patent_app_number] => 14/681020
[patent_app_country] => US
[patent_app_date] => 2015-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 9041
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14681020
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/681020 | METHOD OF INHIBITING XANTHINE OXIDASE ACTIVITY IN A CELL | Apr 6, 2015 | Abandoned |